Visser Hetty M, Van Der Mast Roos C
De Geestgronden, Institute for Mental Health Care, Hoofddorp, The Netherlands.
World J Biol Psychiatry. 2005;6(4):231-41. doi: 10.1080/15622970510029885.
The literature cautions against the induction of (hypo)mania owing to the use of antidepressants in bipolar disorder. Objectives of this review are to examine: (1) the evidence for this assumption; (2) underlying risk factors; and (3) the extent to which a mood stabilizer may be protective.
A systematic literature review was conducted.
Thirteen relevant studies were included. All of them had methodological shortcomings. Overall, there is no strong evidence that use of antidepressants in bipolar disorder increases the risk of (hypo)mania. Possible, although unreplicated, risk factors are: a short allele of the promoter region of the serotonin transporter gene SCL6A4, substance abuse or dependence, multiple antidepressant trials, lower number of previous manias, less delusions during illness, depressive polarity at illness onset, and rapid cycling that has, however, been contradicted by another study. Subtype of bipolar disorder (I or II) has been considered in four studies, with conflicting results. Mood stabilizers are possibly protective.
There is an urgent need for adequate studies of sufficient size. For the time being, treatment of bipolar depression may best be based on the results of the life chart of the individual patient keeping in mind the risk factors found until now.
文献警示双相情感障碍患者使用抗抑郁药可能诱发(轻)躁狂。本综述的目的是研究:(1)这一假设的证据;(2)潜在风险因素;(3)心境稳定剂的保护程度。
进行系统的文献综述。
纳入13项相关研究。所有研究均存在方法学缺陷。总体而言,尚无有力证据表明双相情感障碍患者使用抗抑郁药会增加(轻)躁狂风险。可能的风险因素(虽未得到重复验证)包括:血清素转运体基因SCL6A4启动子区域的短等位基因、物质滥用或依赖、多次抗抑郁药试验、既往躁狂发作次数较少、患病期间妄想较少、发病时为抑郁相以及快速循环发作(然而另一项研究对此提出了反驳)。四项研究考虑了双相情感障碍的亚型(I型或II型),结果相互矛盾。心境稳定剂可能具有保护作用。
迫切需要开展足够规模的充分研究。目前,双相抑郁的治疗最好基于个体患者的生活图表结果,并牢记目前已发现的风险因素。